Difference between revisions of "Danaparoid (Orgaran)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Venous thromboembolism (VTE) medications" to "Category:Venous thromboembolism medications") |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | * | + | *2001-06-26: Initial approval |
==Also known as== | ==Also known as== | ||
| Line 15: | Line 15: | ||
[[Category:Low molecular weight heparins]] | [[Category:Low molecular weight heparins]] | ||
| − | [[Category:Heparin-induced thrombocytopenia medications]] | + | [[Category:Heparin-induced thrombocytopenia medications (historic)]] |
| − | [[Category:Venous thromboembolism medications]] | + | [[Category:Venous thromboembolism medications (historic)]] |
[[Category:FDA approved in 2001]] | [[Category:FDA approved in 2001]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
Latest revision as of 04:23, 5 June 2023
General information
Class/mechanism: Low molecular weight heparin
History of changes in FDA indication
- 2001-06-26: Initial approval
Also known as
- Brand name: Orgaran